National Institutes of Health chief Francis Collins turned down a private lab’s request for federal research funding approval of 47 human embryonic stem cell lines, many of them with genes for diseases such as muscular dystrophy or cystic fibrosis. Collins approved ei lines from academic centers, bringing the total number of NIH approved cell lines to 75.
Office of Strategic Communication